KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Inventory (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Inventory for 17 consecutive years, with $14.2 billion as the latest value for Q4 2025.

  • Quarterly Inventory rose 14.04% to $14.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.2 billion through Dec 2025, up 14.04% year-over-year, with the annual reading at $14.2 billion for FY2025, 14.04% up from the prior year.
  • Inventory hit $14.2 billion in Q4 2025 for Johnson & Johnson, roughly flat from $14.1 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $14.2 billion in Q4 2025 to a low of $9.3 billion in Q1 2021.
  • Historically, Inventory has averaged $11.7 billion across 5 years, with a median of $11.4 billion in 2022.
  • Biggest five-year swings in Inventory: increased 16.55% in 2023 and later dropped 11.13% in 2024.
  • Year by year, Inventory stood at $10.4 billion in 2021, then grew by 12.4% to $11.7 billion in 2022, then dropped by 4.23% to $11.2 billion in 2023, then rose by 11.3% to $12.4 billion in 2024, then increased by 14.04% to $14.2 billion in 2025.
  • Business Quant data shows Inventory for JNJ at $14.2 billion in Q4 2025, $14.1 billion in Q3 2025, and $13.4 billion in Q2 2025.